Third View Private Wealth
EW icon

Third View Private Wealth’s Edwards Lifesciences EW Stock Holding History

Third View Private Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$522K Sell
6,052
-1,782
-23% -$158K 0.06% 168
2026
Q2 		$709K Buy
7,834
+3,147
+67% +$264K 0.09% 154
2026
Q1 		$375K Buy
4,687
+5
+0.1% +$412 0.05% 200
2025
Q4 		$399K Buy
+4,682
New +$384K 0.05% 193

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Third View Private Wealth's EW Position: Q3 2026 in Review

Third View Private Wealth reduced its Edwards Lifesciences (EW) stake by 23% in Q3 2026, selling an estimated $158K and leaving 6,052 shares worth $522K. The position accounts for 0.06% of the portfolio, ranked #168.

Third View Private Wealth first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $709K in Q2 2026. 719 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Third View Private Wealth held 6,052 shares of Edwards Lifesciences worth $522K as of Q3 2026.
  • Third View Private Wealth sold 1,782 Edwards Lifesciences shares in Q3 2026, an estimated $158K.
  • Edwards Lifesciences made up 0.06% of Third View Private Wealth's portfolio in Q3 2026, its #168 holding.
  • Third View Private Wealth first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
  • Third View Private Wealth's Edwards Lifesciences position peaked at $709K in Q2 2026.
  • 719 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Third View Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.